Contributors This version of the guidance was reviewed and agreed in Summer 2015, by a working group comprising: Maria Zambon, Deputy Director, National Infections Service, Public Health England Richard Pebody, Interim Head of Respiratory Diseases Department, National Infections Service, Public Health England Gavin Dabrera, Interim Head of Influenza Preparedness and Response, Respiratory Diseases Department, Public Health England Paul Cleary, Consultant Epidemiologist, National Infections Service, Public Health England Joanna Ellis, Clinical Scientist, National Infections Service, Public Health England Frances Parry-Ford, Respiratory Diseases Scientist, National Infections Service, Public Health England Matthew Donati, Consultant Medical Virologist, Public Health England Bristol Public Health Laboratory and University Hospitals Trust Bristol NHS Foundation Trust Meera Chand, Consultant Medical Microbiologist, Public Health England and Guy’s & St NHS Foundation Trust Thomas’ Philip Howard, Consultant Antimicrobial Pharmacist, Leeds Teaching Hospitals NHS Trust Mark Borthwick, Consultant Pharmacist, John Radcliffe Hospital Arlene Reynolds, Senior Epidemiologist, Health Protection Scotland We would like to acknowledge the contributions of: Jim McMenamin, Consultant Epidemiologist, Health Protection Scotland Senior Critical Care Specialist, Royal Free Hospital Bryan O’Farrell, Steve Tomlin, Consultant Pharmacist, Hospital Children’s Services, St Thomas’ Rob Shulman, Lead Critical Care Pharmacist, University College London Hospital Sarah Lock, Consultant in Communicable Disease Control, Public Health England
Contributors This version of the guidance was reviewed and agreed in Summer 2015, by a working group comprising: Maria Zambon, Deputy Director, National Infections Service, Public Health England Richard Pebody, Interim Head of Respiratory Diseases Department, National Infections Service, Public Health England Gavin Dabrera, Interim Head of Influenza Preparedness and Response, Respiratory Diseases Department, Public Health England Paul Cleary, Consultant Epidemiologist, National Infections Service, Public Health England Joanna Ellis, Clinical Scientist, National Infections Service, Public Health England Frances Parry-Ford, Respiratory Diseases Scientist, National Infections Service, Public Health England Matthew Donati, Consultant Medical Virologist, Public Health England Bristol Public Health Laboratory and University Hospitals Trust Bristol NHS Foundation Trust Meera Chand, Consultant Medical Microbiologist, Public Health England and Guy’s & St Thomas’ NHS Foundation Trust Philip Howard, Consultant Antimicrobial Pharmacist, Leeds Teaching Hospitals NHS Trust Mark Borthwick, Consultant Pharmacist, John Radcliffe Hospital Arlene Reynolds, Senior Epidemiologist, Health Protection Scotland We would like to acknowledge the contributions of: Jim McMenamin, Consultant Epidemiologist, Health Protection Scotland Bryan O’Farrell, Senior Critical Care Specialist, Royal Free Hospital Steve Tomlin, Consultant Pharmacist, Children’s Services, St Thomas’ Hospital Rob Shulman, Lead Critical Care Pharmacist, University College London Hospital Sarah Lock, Consultant in Communicable Disease Control, Public Health England
PHE_guidance_on_use_of_antiviral_agents_for_the_treatment_and_prophylaxis_of__Vm9xXKz.docx